PCN Insights, News, Videos, and More

Perfectionist traits are associated with severe alcohol use disorder (AUD), according to a new study published in the journal Alcoholism: Clinical & Experimental Research.

Treating psychiatric disorders in children and adolescents with psychotropic medication does not increase the risk of SUD. It appears to reduce the risk in individuals with pediatric ADHD, MDD, and psychotic disorders.

Researchers from Macquarie University in Australia have identified several blood-based biomarkers that may reflect the core hallmarks of Alzheimer disease and could help create an early diagnosis test.

In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.

Sublingual, at-home ketamine-assisted therapy over 4 weeks was safe and effective for patients with moderate to severe anxiety and depression in what is thought to be the largest study to date of any type of ketamine treatment.

Adial Pharmaceuticals announced that in its ONWARD Phase 3 clinical study, its AD04 medication achieved a statistically significant mean reduction in heavy drinking days among a prespecified group of “heavy drinkers” compared to a placebo.

Obstructive sleep apnea (OSA) was associated with impaired cognitive performance and white matter integrity over 4 years of follow-up, according to study results published online in JAMA Network Open.

Citing patient safety concerns, Health Canada recently halted a Phase II clinical trial of MDMA-assisted psychotherapy being conducted in Toronto.